Living alone is associated with an increased risk for death from multiple causes, especially among adults aged 18 to 64 years ...
A study of 87,577 adults who wore light-sensing wrist devices found that spending less than 42 minutes a day in bright ...
A longitudinal analysis of 6,096 CHARLS participants found that a higher frailty index, stress-hyperglycemia ratio, and their ...
For patients undergoing elective intestinal resection for Crohn disease (CD), cumulative surgical recurrence rates are lower ...
A 37-year U.S. cohort study of 1,648 men published in the American Journal of Public Health found that Black fathers were ...
A new review maps how FLT3 inhibitors became standard therapy across newly diagnosed and relapsed AML while trials test ...
Genmab stock surged on strong Phase 3 cancer data, but valuation and patent risks remain. Click here to read this recent ...
Moderna made $389 million of revenue in Q1 and $145 million in Q2, so H1 came to $534 million against $250 million last year.
The phase 3 trial found the greatest progression-free survival benefit in patients receiving third-line or later treatment, ...
A study demonstrated an association between air pollution and a higher risk for glaucoma, cataract and age-related macular ...
GINA 2026 no longer endorses a SABA alone for asthma, yet albuterol labels still list only bronchospasm. Airsupra adds exacerbation risk reduction for adults.
OPTIMA shows Prosigna assay can help many ER-positive, HER2-negative breast cancer patients safely avoid chemotherapy.